Mesenchymal Stem Cells (MSCs)
Mesenchymal Stem Cells (MSCs) is a biological therapy with 11 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
40.0%
2 of 5 finished
60.0%
3 ended early
3
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
Stem Cells for the Treatment of Pouchitis
Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's
Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis
Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation Proctitis
Clinical Trials (11)
Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
Stem Cells for the Treatment of Pouchitis
Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's
Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis
Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation Proctitis
Evaluate the Distribution and Dynamic Behavior of TH-SC01 Cells in Vivo in Patients With Perianal Fistula
Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells
Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing
Mesenchymal Stem Cells for Age-Related Frailty
Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies
Mensenchymal Stem Cell (MSC) Included in OrthADAPT Membrane for Rotator Cuff Tears Repair
All 11 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 11